Toinvestigate a potential link, Drug Bank pharmacology information wasutilized. Albumin-interacting compoundsfrom the cholestasis and DILI rank data sets were manually classifiedfrom the literature into four plasma protein binding categories: high(≥90% or term like “highly plasma protein bound”),medium (60–90%), low (<60%) binding, and inconclusive orno evidence. The gene discussed is ALB; the disease is cholestasis.